|
|
Volumn 5, Issue 2-4, 2005, Pages 201-205
|
|
Future advances in addiction treatment
|
|
Author keywords
Addiction treatment; Cocaine; Future prospects; Marijuana; Opioid dependence
|
|
Indexed keywords
ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;
AMPA RECEPTOR ANTAGONIST;
BUPRENORPHINE;
BUPRENORPHINE PLUS NALOXONE;
CANNABIDIOL;
CANNABIS;
COCAINE;
COCAINE VACCINE;
CORTICOTROPIN RELEASING FACTOR ANTAGONIST;
DISULFIRAM;
DOPAMINE 1 RECEPTOR BLOCKING AGENT;
DOPAMINE 1 RECEPTOR STIMULATING AGENT;
DRONABINOL;
FENTANYL;
HYDROCODONE;
LONG ACTING DRUG;
METHADONE;
METHAMPHETAMINE;
MODAFINIL;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NALTREXONE;
OPIATE;
OPIATE AGONIST;
OXYCODONE;
PSYCHOSTIMULANT AGENT;
RIMONABANT;
SR 141678;
TIAGABINE;
TOPIRAMATE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VACCINE;
ACTIVE IMMUNIZATION;
ARTICLE;
BEHAVIOR THERAPY;
CANNABIS ADDICTION;
CLINICAL TRIAL;
COCAINE DEPENDENCE;
DRUG ABSORPTION;
DRUG COST;
DRUG DEPENDENCE;
DRUG DEPENDENCE TREATMENT;
DRUG DETOXIFICATION;
DRUG INDICATION;
DRUG MARKETING;
DRUG MECHANISM;
EDUCATION;
EUPHORIA;
HUMAN;
MAINTENANCE THERAPY;
OPIATE ADDICTION;
PASSIVE IMMUNIZATION;
PATIENT COMPLIANCE;
PRESCRIPTION;
PRIORITY JOURNAL;
RELAPSE;
SOCIAL INTERACTION;
VACCINATION;
VOCATION;
WITHDRAWAL SYNDROME;
|
|
EID: 27944436108
PISSN: 15662772
EISSN: None
Source Type: Journal
DOI: 10.1016/j.cnr.2005.09.001 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
